Inducible nitric oxide synthase and nitrotyrosine are found in monocytes/macrophages and/or astrocytes in acute, but not in chronic, multiple sclerosis

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 4, 1998, Pages 438-445

  Oleszak, Emilia L ^a   Zaczynska, Ewa ^a   Bhattacharjee, Meena ^b   Butunoi, Catalin ^c   Legido, Agustin ^d   Katsetos, Christos D ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c Rocky Mountain MS Center   (United States)

^d ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; TYROSINE; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; AGED; ARTICLE; ASTROCYTE; CHILD; CHRONIC DISEASE; CLINICAL ARTICLE; DEMYELINATION; FEMALE; GLIA CELL; HUMAN; IMMUNOREACTIVITY; MACROPHAGE; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; WHITE MATTER;

EID: 0031859370     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.4.438-445.1998     Document Type: Article

References (69)

1. Adams, C. W., and R. N. Poston. 1990. Macrophage histology in paraffin-embedded multiple sclerosis plaques is demonstrated by the monoclonal pan-macrophage marker HAM-56: correlation with chronicity of the lesion. Acta Neuropathol. 80:208-211.
2. Adams, C. W. M., R. N. Poston, and S. J. Buk. 1989. Pathology. histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J. Neurol. Sci. 92:291-306.
3. Bagasra, O., F. H. Michaels, Y. M. Zheng, L. E. Bobroski, S. V. Spitsin, Z. F. Fu, R. Tawadros, and H. Koprowski. 1997. Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis. Proc. Natl. Acad. Sci. USA 92:12041-12045.
4. Beckman, J. S., and J. P. Crow. 1993. Pathological implications of nitric oxide, Superoxide and peroxynitrite formation. Biochem. Soc. Trans. 21:330-334.
5. Beckman, J. S., Y. Z. Ye, P. G. Anderson, J. Chen, M. A. Accavitti, M. M. Tarpey, and C. R. White. 1994. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe-Seyler 375:81-88.
6. Benveniste, E. N. 1997. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. 75:165-173.
7. Bi, Z., and C. S. Reiss. 1995. Inhibition of vesicular stomatitis virus infection by nitric oxide. J. Virol. 69:2208-2213.
8. Bö, L., T. M. Dawson, S. Wesselingh, S. Mörk, S. Choi, P. A. Kong, D. Hanley, and B. Trapp. 1994. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:778-786.
9. Bogdan, C., Y. Vodovotz, J. Paik, Q.-W. Xie, and C. Nathan. 1994 Mechanism of suppression of nitric oxide synthase expression by interleukin-4 in primary mouse macrophages. J. Leukocyte Biol. 55:227-233.
10. Boje, K. M., and P. K. Arora. 1992. Microglia-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res. 587:250 256.
11. Bolanos, J. P., S. J. R. Heales, J. M. Land, and J. B. Clark. 1995. Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem. 64:1965-1972.
12. Brenner, T., S. Brocke, F. Szafer, R. A. Sobel, J. F. Parkinson, D. H. Perex, and L. Steinman. 1997. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis. J. Immunol. 158:2940-2946.
13. Brosnan, C. F., L. Battistini, C. S. Raine, D. W. Dickson, A. Casadevall, and S. C. Lee. 1994. Reactive nitrogen intermediates in human neuropathology: an overview. Dev. Neurosci. 16:152-161.
14. Chao, C. C., S. Hu, T. W. Molitor, E. G. Shaskan, and P. K. Peterson. 1992. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J. Immunol. 149:2736-2741.
15. Chesrown, S. E., J. Monier, G. Visner, and H. S. Nick. 1994. Regulation of inducible nitric oxide synthase mRNA levels by LPS, IFN-γ, TGF-β, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem. Biophys. Res. Commun. 200:126-134.
16. Corradin, S. B., N. Fasel, Y. Buchmüller-Rouiller, A. Ransijn, J. Smith, and J. Manuel. 1993. Induction of macrophage nitric oxide production by interferon-γ and tumor necrosis factor-α is enhanced by interleukin-10. Eur. J. Immunol. 23:2045-2048.
17. Croen, K. D. 1993. Evidence for an antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest. 91:2446-2452.
18. Cross, A. H., T. P. Misko, R. F. Lin, W. F. Hickey, J. L. Trotter, and R. G. Tilton. 1994. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J. Clin. Invest. 93:2684-2690.
19. Cunha, F. Q., S. Moncada, and F. Y. Liew. 1992. Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by Interferon-γ in murine macrophages. Biochem. Biophys. Res. Commun. 182:1155-1159.
20. Dawson, V. L., T. M. Dawson, E. D. London, D. S. Bredt, and S. H. Snyder. 1991. Nitric oxide mediates glutamate neurotoxicity in primary cultures. Proc. Natl. Acad. Sci. USA 88:6368-6371.
21. DeGroot, C. J. A., S. R. Ruuls, J. W. M. Theeuwes, C. D. Dukstra, and P. Van der Valk. 1997. Immunocytochemical characterization of the expression of inducible and constitutive isoforms on nitric oxide synthase in demyelinating multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 56:10-20.
22. Galea, E., D. J. Reis, and D. L. Feinstein. 1994. Cloning and expression of inducible nitric oxide synthase from rat astrocytes. J. Neurosci. Res. 37:406-414.
23. Giovannoni, G., S. J. R. Heales, N. C. Silver, J. O'Riordan, R. F. Miller, J. M. Land, J. B. Clark, and E. J. Thompson. 1997. Raised serum nitrate and nitrite levels in patients with multiple sclerosis. J. Neurol. Sci. 145:77-81.
24. Good, P. F., P. Werner, A. Hsu, C. W. Olanow, and D. P. Perl. 1966. Evidence for neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149: 21-28.
25. Grzybicki, D. M., K. B. Kwack, S. Perlman, and S. P. Murphy. 1997. Nitric oxide synthase type II expression by different cell types in MHV-JHM encephalitis suggests distinct roles for nitric oxide in acute versus persistent virus infection. J. Neuroimmunol. 73:15-27.
26. Hewett, S. J., J. A. Corbett, M. L. McDaniel, and D. W. Choi. 1993. Interferon-γ and interleukin-1β induce nitric oxide formation from primary mouse astrocytes. Neurosci. Lett. 164:229-232.
27. Hooper, D. C., S. T. Ohnishi, R. Kean, Y. Numagami, B. Dietzschold, and H. Koprowski. 1995. Local nitric oxide production in viral and autoimmune diseases of the CNS. Proc. Natl. Acad. Sci. USA 92:5312-5316.
28. Hooper, D. C., O. Bagasra, J. C. Marini, A. Sborek, S. T. Ohnishi, R. Kean, J. M. Champion, A. B. Sarker, L. Bobroski, J. L. Farber, T. Akaike, H. Maeda, and H. Koprowski. 1997. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA 94:2528-2533.
29. Hunter, M. I. S., B. C. Niemadim, and D. L. W. Davidson. 1989. Lipid peroxidation production and antioxidant proteins in plasma and cerebrospinal fluid from multiple sclerosis. J. Clin. Immunol. 10:1645-1652.
30. Ialenti, A., A. Ianaro, S. Moncada, and M. Di Rosa. 1992. Modulation of acute inflammation by endogenous nitric oxide. Eur. J. Pharmacol. 211:177-182.
31. Inoue, S., and S. Kawanishi. 1995. Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide. FEBS Lett. 371:86-88.
32. Johnson, A. W., J. M. Land, E. J. Thompson, J. P. Bolanos, J. B. Clark, and S. R. Heales. 1995. Evidence for increased nitric oxide production in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 58:107.
33. Kepes, J. J. 1993. Large focal tumor-like demyelinating lesions of the brain; intermediate entity between multiple sclerosis and acute disseminated encephalomyelitis? A study of 31 patients. Ann. Neurol. 33:18-27.
34. Kolb, H., and V. Kolb-Bachofen. 1992. Nitric oxide: a pathogenic factor in autoimmunity. Immunol. Today 13:157-160.
35. Kooy, N. W., J. A. Royall, Y. Z. Ye, D. R. Kelly, and J. S. Beckman. 1995. Evidence for in vivo peroxynitrite production in human acute lung injury. Am. J. Respir. Crit. Care Med. 151:1250-1254.
36. Koprowski, H., Y. M. Zhen, E. Heber-Katz, N. Fraser, L. Rorke, Z. F. Fu, C. Hanlon, and B. Dietzschold. 1993. In vivo expression of inducible nitric oxide synthase in experimentally induced neurologic diseases. Proc. Natl. Acad. Sci. USA 90:3024-3027.
37. Kreil, T. R., and M. M. Eibl. 1996. Nitric oxide and viral infection: no antiviral activity against a flavivirus in vitro, and evidence for contribution to pathogenesis in experimental infection in vivo. Virology 219:304-306.
38. Lee, S. C., D. W. Dickson, W. Liu, and C. F. Brosnan. 1993. Induction of nitric oxide synthase activity in human astrocytes by IL-1β and IFN-γ. J. Neuroimmunol. 46:19-24.
39. Lehmann, P. V., T. Forsthuber, A. Miller, and E. E. Sercarz. 1992. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 358:155-157.
40. Lepoivre, M., F. Fieschi, J. Coves, L. Thelander, and M. Fontecave. 1991. Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun. 179:442-448.
41. Lipton, S. A., Y. B. Choi, Z. H. Pan, S. Z. Lei, H. S. V. Chen, N. J. Sucher, J. Loscalzo, D. J. Singel, and J. S. Stamier. 1993. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitrosocompounds. Nature 364:626-631.
42. Lowenstein, C. J., S. L. Hill, A. Lafond-Walker, J. Wu, G. Allen, M. Landavere, N. R. Rose, and A. Herskowitz. 1996. Nitric oxide inhibits viral replication in murine myocarditis. J. Clin. Invest. 97:1837-1843.
43. Marlena, M. A. 1993. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268:12231-12234.
44. Marletta, M. A., P. S. Yocr, R. Lyengar, C. D. Leaf, and J. S. Wishnok. 1988. Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry 27:8706-8711.
45. Martin, B. L., D. Wu, S. Jakes, and D. J. Graves. 1990. Chemical influences on the specificity of tyrosine phosphorylation. J. Biol. Chem. 265:7108-7111.
46. Mendez, M. F., and S. Pogacar. 1988. Malignant monophasic multiple sclerosis or "Marburg's disease." Neurology 38:1153-1155.
47. Merrill, J. E., L. J. Ignarro, M. P. Sherman, J. Melinek, and T. E. Lane. 1993. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:2132-2141.
48. Minc-Golomb, D., I. Tsarfaty, and J. P. Schwartz. 1994. Expression of inducible nitric oxide synthase by neurones following exposure to endotoxin and cytokine. Br. J. Pharmacol. 112:720-722.
49. Mitrovic, B., L. J. Ignarro, S. Montestruque, A. Smoll, and J. E. Merrill. 1994. Nitric oxide as a potential pathological mechanism in demyelination: its differential effects on primary glial cells in vitro. Neuroscience 61:575-585.
50. Nathan, C., and Q.-W. Xie. 1994. Regulation of biosynthesis of nitric oxide. J. Biol. Chem. 269:13725-13728.
51. Nathan, C., and Q.-W. Xie. 1994. Nitric oxide synthases: roles, tolls and controls. Cell 78:915-918.
52. Nussler, A. K., and T. R. Billiar. 1993. Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukocyte Biol. 54:171-178.
53. Okuda, Y., S. Sakoda, H. Fujimura, and T. Yanagihara. 1997. Nitric oxide via an inducible isoform of nitric oxide synthase is a possible factor to eliminate inflammatory cells from the central nervous system of mice with experimental allergic encephalomyelitis. J. Neuroimmunol. 73:107-116.
54. Oleszak, E. L., G. Murdoch, L. Manuelidis, and E. E. Manuelidis. 1988. Growth factor production by Creutzfeldt-Jacob disease cell lines. J. Virol. 62:3103-3108.
55. Oleszak, E. L., J. Kuzmak, R. A. Good, and C. D. Platsoucas. 1995. Immunobiology of TMEV infection. Immunology of Theiler's murine encephalomyelitis virus infection. Immunol. Res. 14:13-33.
56. Oleszak, E. L., C. D. Katsetos, J. Kuzmak, and A. Varadhachary. 1997. Inducible nitric oxide synthase in Theiler's murine encephalomyelitis virus infection. J. Virol. 71:3228-3235.
57. Parkinson, J. F., B. Mirtovic, and J. E. Merrill. 1997. The role of nitric oxide in multiple sclerosis. J. Mol. Med. 75:174-186.
58. Prineas, J. W., and W. I. McDonald. Demyelinating diseases, p. 813-896. In D. I. Graham and P. L. Lantos (ed.), Greenfield's neuropathology, 6th ed., chapter 13. Arnold, London, United Kingdom.
59. Radi R., J. S. Beckman, K. M. Bush, and B. A. Freeman. 1991. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of Superoxide and nitric oxide. J. Biol. Chem. 266:4244-4250.
60. Rodriguez, M., E. Oleszak, and J. Leibowitz. 1987. Theiler's murine encephalomyelitis: a model of demyelination and persistence of virus. CRC Crit. Rev. Immunol. 7:325-365.
61. Tucker, P. C., D. E. Griffin, S. Choi, N. Bui, and S. Wesselingh. 1996. Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis. J. Virol. 70:3972-3977.
62. Van Dam, A.-M., J. Bauer, W. K. H. Man-A-Hing, C. Marquette, F. J. H. Tilders, and F. Berkenbosch. 1995. Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin. J. Neurosci. Res. 40:251-260.
63. Voskuhl, R. R., R. W. Farris II, K. Nagasato, H. F. McFarland, and M. D. Dalcq. 1996. Epitope spreading occurs in active but not passive EAE induced by myclin basic protein. J. Neuroimmunol. 70:103-111.
64. Wei, X., I. G. Charles, A. Smith, J. Ure, G. Feng, F. Huang, D. Xu, W. Muller, S. Moncada, and F. Y. Liew. 1995. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375:408-411.
65. Weinberg, J. B., M. A. Misukonis, P. J. Shami, S. N. Mason, D. L. Sauls, W. A. Dittman, E. R. Wood, G. K. Smith, B. McDonald, K. E. Bachus, A. F. Hancy, and D. L. Granger. 1995. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production of blood monocytes and peritoneal macrophages. Blood 86:1184-1195.
66. Wink, D. A., K. S. Kasprzak, C. M. Maragos, R. K. Elespuru, M. Misra, T. M. Dunams, T. A. Cebula, W. H. Koch, A. W. Andrews, J. S. Allen, and L. K. Keefer. 1991. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254:1001-1003.
67. Wink, D. A., and J. Laval. 1994. The Fpg protein, a DNA repair enzyme, is inhibited by the biomediator nitric oxide in vitro and in vivo. Carcinogenesis 15:2125-2129.
68. Yu, M., J. M. Johnson, and V. K. Tuohy. 1996. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease. J. Exp. Med. 183:1777-1788.
69. Zielasek, J., S. Jung, R. Gold, F. Y. Liew, K. V. Toyka, and H. P. Hartung. 1995. Administration of nitric oxide synthase inhibitors in experimental autoimmune neuritis and experimental autoimmune encephalomyelitis. J. Neuroimmunol. 58:81-88.